376 related articles for article (PubMed ID: 15708245)
1. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
Pos F; Horenblas S; Dom P; Moonen L; Bartelink H
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):678-86. PubMed ID: 15708245
[TBL] [Abstract][Full Text] [Related]
2. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
[TBL] [Abstract][Full Text] [Related]
3. Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience.
Nieuwenhuijzen JA; Pos F; Moonen LM; Hart AA; Horenblas S
Eur Urol; 2005 Aug; 48(2):239-45. PubMed ID: 16005375
[TBL] [Abstract][Full Text] [Related]
4. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.
van Onna IE; Oddens JR; Kok ET; van Moorselaar RJ; Bosch JL; Battermann JJ
Eur Urol; 2009 Jul; 56(1):113-21. PubMed ID: 18722048
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
[TBL] [Abstract][Full Text] [Related]
6. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
7. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
8. [Conservative surgery and iridium 192 in stage pT2 bladder tumor. A 5-year follow up].
Schlosser J; Hubert J; Hoffstetter S; Six A; Pfeiffert D; Mangin P; Pernot M
Prog Urol; 1997 Dec; 7(6):953-9. PubMed ID: 9490140
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
[TBL] [Abstract][Full Text] [Related]
10. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
11. Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up.
Given RW; Parsons JT; McCarley D; Wajsman Z
Urology; 1995 Oct; 46(4):499-504; discussion 504-5. PubMed ID: 7571218
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands study.
van der Steen-Banasik E; Ploeg M; Witjes JA; van Rey FS; Idema JG; Heijbroek RP; Karthaus HF; Reinders JG; Viddeleer A; Visser AG
Radiother Oncol; 2009 Nov; 93(2):352-7. PubMed ID: 19457565
[TBL] [Abstract][Full Text] [Related]
13. [Good results of bladder-preserving treatment in poorly differentiated and invasive bladder carcinoma using interstitial Iridium-192 radiotherapy].
Moonen LM; Horenblas S; Pos F; Schaefer BS; Meinhardt W; Bartelink H
Ned Tijdschr Geneeskd; 1996 Jul; 140(27):1406-10. PubMed ID: 8766684
[TBL] [Abstract][Full Text] [Related]
14. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
[TBL] [Abstract][Full Text] [Related]
15. [Interstitial brachytherapy in infiltrating cancer of the bladder. The Nancy experience].
Hoffstetter S; Hubert J; Guillemin F; Peiffert D; Marchal C; Luporsi E; Pernot M
Cancer Radiother; 1998 Apr; 2 Suppl 1():54s-61s. PubMed ID: 9749080
[TBL] [Abstract][Full Text] [Related]
16. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
18. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
Tran E; Souhami L; Tanguay S; Rajan R
Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
[TBL] [Abstract][Full Text] [Related]
19. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
